Effect of Weight Loss (WL) on Concomitant Medication Costs in Obese/Overweight individuals with Metabolic Syndrome (METS) receiving Phentermine/Topiramate extended-release (PHEN/TPM ER)
Abstract
Authors
S. Kahan S. Karnawat
S. Kahan S. Karnawat
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now